IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.

Abstract:

OBJECTIVE:To determine whether the intrathecal concentrations of cytokines/chemokines are associated with, or influenced by, serum concentrations in patients with central neuropsychiatric systemic lupus erythematosus (NPSLE), and to ascertain whether the increased production of cytokines/chemokines intrathecally relative to serum levels is associated with the presence of central NPSLE. METHODS:52 SLE patients (30 with central NPSLE and 22 with non-NPSLE), for whom the CSF and serum samples were obtained at the same time, were enrolled. 27 kinds of cytokine/chemokine concentrations other than IFN-α in the cerebrospinal fluid (CSF) and serum samples were measured by Bio-Plex Pro Assays. IFN-α concentration and anti-ribosomal P protein antibody (anti-P) titres in CSF and serum samples were measured by ELISA. RESULTS:The mean concentrations of IL-6, IL-8, IP-10, MCP-1, G-CSF and GM-CSF were higher in the CSF than in the sera, respectively, while the mean concentrations of other 22 cytokines/chemokines, including RANTES and IFN-α, in the CSF were much lower than those in the sera, respectively. Furthermore, the concentrations of IL-6, IL-8, IP-10, MCP-1 and G-CSF in the CSF of the 30 patients with NPSLE were significantly higher than in the 22 patients with non-NPSLE (p = 6.82 × 10(-5), p = 0.00037, p = 0.0028, p = 0.00065, and p = 0.0001, respectively), while the concentration of GM-CSF in the CSF of the 30 patients with NPSLE was not significantly higher than in the 22 patients with non-NPSLE. Most importantly, the largest difference occurred in CSF IL-6 concentrations. A significant positive correlation between CSF anti-P titres and serum anti-P titres in 52 patients with SLE (r = 0.6316, p = 6.44 × 10(-6)) was found, while no significant positive correlation was observed between CSF levels and serum levels of each cytokine/chemokine in the 52 SLE patients. CONCLUSION:In central NPSLE the production of IL-6, IL-8, IP-10, MCP-1 and G-CSF might take place in the central nervous system (CNS). These increased CSF cytokines/chemokines along with anti-P might have a prerequisite role in the pathogenesis of central NPSLE.

journal_name

Lupus

journal_title

Lupus

authors

Yoshio T,Okamoto H,Kurasawa K,Dei Y,Hirohata S,Minota S

doi

10.1177/0961203316629556

subject

Has Abstract

pub_date

2016-08-01 00:00:00

pages

997-1003

issue

9

eissn

0961-2033

issn

1477-0962

pii

0961203316629556

journal_volume

25

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Ultrasonographic abnormalities and inter-reader reliability in Danish patients with systemic lupus erythematosus - a comparison with clinical examination of wrist and metacarpophalangeal joints.

    abstract:OBJECTIVES:We aimed to determine 1) ultrasound (US) abnormalities in patients with systemic lupus erythematosus (SLE) with and without hand arthralgia at the day of examination compared with clinical evaluation and healthy controls, and 2) inter-observer reliability of the US abnormalities. METHODS:Thirty-three female...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314561666

    authors: Dreyer L,Jacobsen S,Juul L,Terslev L

    更新日期:2015-06-01 00:00:00

  • The illness experience of youth with lupus/mixed connective tissue disease: a mixed methods analysis of patient and parent perspectives.

    abstract:OBJECTIVE:We aimed to develop a model of the illness experience for youth with systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD). METHODS:We conducted 32 semi-structured interviews with 16 outpatient youth with SLE/MCTD, age 11 to 22 years, and their parents. We qualitatively defined key featur...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646460

    authors: Knight A,Vickery M,Fiks AG,Barg FK

    更新日期:2016-08-01 00:00:00

  • Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.

    abstract::Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of e...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309358187

    authors: Ortega LM,Schultz DR,Lenz O,Pardo V,Contreras GN

    更新日期:2010-04-01 00:00:00

  • Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.

    abstract::Objectives We analyzed the clinical follow-up results of 88 lupus nephritis patients to find prognostic factors for the development of chronic kidney disease in ethnically homogeneous Korean patients with biopsy-proven lupus nephritis. Methods Sociodemographic, clinical, laboratory, and treatment-related data at the t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317694257

    authors: Park DJ,Kang JH,Lee JW,Lee KE,Kim TJ,Park YW,Lee JS,Choi YD,Lee SS

    更新日期:2017-10-01 00:00:00

  • Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.

    abstract::The complexity of the therapeutic approach in systemic lupus erythematosus (SLE) is increased by the large number of patients who do not respond to the first-line therapies and by relapses after initial clinical remission. In these patients, second-line drugs are often prescribed according to individual clinical decis...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309106174

    authors: Ramos-Casals M,Soto MJ,Cuadrado MJ,Khamashta MA

    更新日期:2009-08-01 00:00:00

  • Antiphospholipid syndrome: clinical and therapeutic aspects.

    abstract::The purpose of the present study was to evaluate patients with the antiphospholipid syndrome with particular attention to their initial clinical features, final diagnoses and the course of thrombotic events in association with therapy. The methodology applied was the following: retrospective analysis of 30 patient fil...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300206

    authors: Vlachoyiannopoulos PG,Tsiakou E,Chalevelakis G,Raptis SA,Moutsopoulos HM

    更新日期:1994-04-01 00:00:00

  • Altered oxidative stress markers in relation to T cells, NK cells & killer immunoglobulin receptors that are associated with disease activity in SLE patients.

    abstract::Systemic Lupus Erythematosus is an autoimmune disease with symptoms pervasive to all organ systems. It affects more females as compared to males (in the ratio 9:1). Oxidative stress plays a major role in the pathogenesis of SLE and other autoimmune diseases. In order to understand the relationship between cell specifi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320959441

    authors: Tandon A,Anupam K,Kaushal J,Gautam P,Sharma A,Bhatnagar A

    更新日期:2020-12-01 00:00:00

  • Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.

    abstract::We investigated the clinical significance of IgG phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in patients with SLE. The study population consisted of 140 patients with SLE. Sera were examined for IgG phospholipid-dependent anti-beta 2-GPI antibodies by ELISA. IgG phospholipid-dependent ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400609

    authors: Kaburaki J,Kuwana M,Yamamoto M,Kawai S,Matsuura E,Ikeda Y

    更新日期:1995-12-01 00:00:00

  • Management of antiphospholipid antibody positivity and elective orthopedic procedures.

    abstract::Current management of primary or secondary antiphospholipid antibody (aPL) syndromes with known embolic phenomena requiring anticoagulation is empiric in the setting of elective orthopedic procedures. Short-term withdrawal of warfarin with continuance of aspirin and glucocorticoid therapy was undertaken for sequential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100311

    authors: Schnitz WM,Lister KA,McCarty GA

    更新日期:1992-05-01 00:00:00

  • Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id beta.

    abstract::We describe a human monoclonal antibody designated WRI 176 beta and a common idiotype that it carries. This antibody was derived from the spleen of a patient with SLE. WRI 176 is an IgM kappa monoclonal reacting with ssDNA, dsDNA, poly(dT) and it is likely that mAb WRI 176 beta is a representative of the so-called nat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300105

    authors: Blanco F,Longhurst C,Watts R,Kalsi J,Wiloch HW,Youinou P,Latchman DS,Isenberg DA

    更新日期:1994-02-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis.

    abstract::Associations of polymorphisms in vitamin D receptor (VDR) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have already been explored by many studies. The aim of this meta-analysis was to better clarify associations between polymorphisms in VDR and RA/SLE by combing the results of all relevant stu...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203320909432

    authors: Zhang WT,Jin TF,Chen L

    更新日期:2020-04-01 00:00:00

  • Parasitic infection and autoimmunity.

    abstract::Systemic lupus erythematosus is the prototypic multi-system autoimmune disease characterized by the production of multiple autoantibodies. The development of disease depends on a genetic predisposition and exposure to environmental factors including UV light, drugs, and infections. The association of parasitic infecti...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309345735

    authors: Zandman-Goddard G,Shoenfeld Y

    更新日期:2009-11-01 00:00:00

  • Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.

    abstract::Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847443

    authors: Fernández-Nebro A,Palacios-Muñoz R,Gordillo J,Abarca-Costalago M,De Haro-Liger M,Rodríguez-Andreu J,González-Santos P

    更新日期:1999-01-01 00:00:00

  • Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.

    abstract::Legionnaire's disease (LD) is most commonly caused by Legionella pneumophila (L. pneumophila). In immunocompromised patients LD can cause necrosis of the lung parenchyma with abscess formation and cavitation. Systemic lupus erythematosus (SLE) is an autoimmune disorder with features of both primary and secondary immun...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203321990102

    authors: Khokher W,Kesireddy N,Adunse J,Mudiyanselage PH,Iftikhar S,Assaly R

    更新日期:2021-01-26 00:00:00

  • Three cases of spondyloenchondrodysplasia (SPENCD) with systemic lupus erythematosus: a case series and review of the literature.

    abstract::Spondyloenchondrodysplasia (SPENCD) is a rare autosomal recessive skeletal dysplasia caused by recessive mutations in the ACP5 gene, and it is characterized by the persistence of chondroid tissue islands within the bone. The clinical spectrum of SPENCD includes neurological involvement and immune dysfunction, such as ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203316629000

    authors: Bilginer Y,Düzova A,Topaloğlu R,Batu ED,Boduroğlu K,Güçer Ş,Bodur I,Alanay Y

    更新日期:2016-06-01 00:00:00

  • Early-stage predictors for treatment responses in patients with active lupus nephritis.

    abstract:OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319826703

    authors: Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

    更新日期:2019-03-01 00:00:00

  • Monoclonal gammopathy in systemic lupus erythematosus.

    abstract::In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339200100410

    authors: Porcel JM,Ordi J,Tolosa C,Selva A,Castro-Salomo A,Vilardell M

    更新日期:1992-08-01 00:00:00

  • Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the relationship between antimalarials (AM) and elevated muscle enzymes in systemic lupus erythematosus (SLE). PATIENTSMETHODS:325 lupus patients with abnormal creatine phosphokinase (CPK) for at least two consecutive clinic visits were enrolled; 54 patients on statins/fibrates (n = 43) and/or...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315617845

    authors: Tselios K,Gladman DD,Su J,Urowitz MB

    更新日期:2016-04-01 00:00:00

  • Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.

    abstract::Background While thrombopoeitin (TPO) agonists that act to simulate platelet production have been approved for use in steroid-refractory chronic immune thrombocytopenia purpura (ITP), there are few data on the safety and efficacy of these medications in patients with concurrent systemic lupus erythematosus (SLE) or an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318770023

    authors: Lusa A,Carlson A

    更新日期:2018-09-01 00:00:00

  • Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.

    abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320911091

    authors: Juthong S,Geater AF,Dekumyoy P,Hortiwakul T,Siripaitoon B,Aiewruengsurat D,Thongbun N

    更新日期:2020-05-01 00:00:00

  • HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.

    abstract::The objective of this study was to determine the HLA class II associations of the anticardiolipin (aCL) and anti-beta2GPI (abeta2GPI) antibodies in a large series of European patients with systemic lupus erythematosus (SLE). A cohort of 577 European SLE patients was enrolled. aCL and abeta2GPI were measured by ELISA m...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1177/096120330000900109

    authors: Galeazzi M,Sebastiani GD,Tincani A,Piette JC,Allegri F,Morozzi G,Bellisai F,Scorza R,Ferrara GB,Carcassi C,Font J,Passiu G,Smolen J,Papasteriades C,Houssiau F,Nebro AF,Ramon Garrido ED,Jedryka-Goral A,Marcolongo R

    更新日期:2000-01-01 00:00:00

  • DNA methylation in systemic lupus erythematosus.

    abstract::Recent studies on epigenetics, including DNA methylation and its regulatory enzymes, seem likely to contribute to elucidation of the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE), although the relationship between DNA methylation and SLE has long been the subject of investigation. To o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu321oa

    authors: Sekigawa I,Okada M,Ogasawara H,Kaneko H,Hishikawa T,Hashimoto H

    更新日期:2003-01-01 00:00:00

  • Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.

    abstract::Background Systemic lupus erythematosus (SLE) is an autoimmune disease marked by the disruption of the immune homeostasis. Patients exhibit a wide range of clinical manifestations, and environmental and genetic factors are involved in SLE pathogenesis. Evidence suggests that abnormalities in the cellular and molecular...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316678671

    authors: Glesse N,Vianna P,Paim LMG,Matte MCC,Aguiar AKK,Palhano PL,Monticielo OA,Brenol CV,Xavier RM,Chies JAB

    更新日期:2017-06-01 00:00:00

  • Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody.

    abstract::We describe a patient with rheumatoid arthritis (RA) whose sera contained a high titre of an antibody targeting cytoplasmic ribosomal P proteins (anti-P). This association preceded by 6 years the development of serological and clinical manifestations of systemic lupus erythematosus (SLE). The clinical significance of ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600910

    authors: Hamasaki K,Mimura T,Kanda H,Morino N,Yazaki Y,Nojima Y

    更新日期:1997-01-01 00:00:00

  • Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.

    abstract::We performed a prospective study to evaluate the efficacy and safety of low-dose cyclosporine A (CSA) treatment in paediatric lupus nephritis refractory to conventional therapy. Seven children with biopsy-proven Class III-IV lupus nephritis were treated with CSA (2-4 mg/kg/day) combined with low-dose prednisone for on...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1191/0961203306lu2312oa

    authors: Baca V,Catalán T,Villasís-Keever M,Ramón G,Morales AM,Rodríguez-Leyva F

    更新日期:2006-01-01 00:00:00

  • Kidney transplantation in lupus patients: a case-control study from a single centre.

    abstract::This study was conducted to determine kidney transplantation (KTx) outcomes for Greek patients with renal failure caused by lupus nephritis (LN) compared with matched controls, kidney recipients with other causes of end-stage renal disease (ESRD). Twenty-six patients with systemic lupus erythematosus (SLE) subjected t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089430

    authors: Lionaki S,Kapitsinou PP,Iniotaki A,Kostakis A,Moutsopoulos HM,Boletis JN

    更新日期:2008-07-01 00:00:00

  • Comparing the 1997 update of the 1982 American College of Rheumatology (ACR-97) and the 2012 Systemic Lupus International Collaborating Clinics (SLICC-12) criteria for systemic lupus erythematosus (SLE) classification: which enables earlier classification

    abstract:OBJECTIVE:We compared the 1997 update of the 1982 American College of Rheumatology (ACR-97) and the 2012 Systemic Lupus International Collaborating Clinics (SLICC-12) criteria, for earlier classification of systemic lupus erythematosus (SLE) in a multiethnic urban Asian SLE population. METHODS:Patients from a retrospe...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318811599

    authors: Low ESH,Krishnaswamy G,Thumboo J

    更新日期:2019-01-01 00:00:00

  • Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy.

    abstract::We report a case of a patient with clinical features of progressive supranuclear palsy and raised titres of anticardiolipin antibodies in blood, thrombocytopenia and livedo reticularis on skin. Magnetic resonance imaging of brain and isotope scan of brain were distinctive of vascular disorder. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu242CR

    authors: Reitblat T,Polishchuk I,Dorodnikov E,Aladjem Z,Turiansky L,Zamir D,Kahana E

    更新日期:2003-01-01 00:00:00

  • Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients.

    abstract::The aim of this study is to determine prevalence, clinical significance of antiphospholipid antibodies (aPL) including anticardiolipin antibodies (aCL), anti-beta2GP1 and lupus anticoagulant (LA) in a cohort of 74 patients with primary Sjögren's syndrome (pSS) according to revised European criteria. aPL were found in ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1006oa

    authors: Fauchais AL,Lambert M,Launay D,Michon-Pasturel U,Queyrel V,Nguyen N,Hebbar M,Hachulla E,Devulder B,Hatron PY

    更新日期:2004-01-01 00:00:00